Andrea Gombos

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi, William Jacot, Toshinari Yamashita et al. · New England Journal of Medicine · 2022 · 2.5K citations · Full text

Medicine, Oncology, Pharmacology +17

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Ann H. Partridge, Samuel M. Niman, Monica Ruggeri et al. · New England Journal of Medicine · 2023 · 215 citations · Full text

Medicine, Endocrinology, Oncology +17

Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative

Philippe Aftimos, Mafalda Oliveira, Alexandre Irrthum et al. · Cancer Discovery · 2021 · 177 citations · Full text

Medicine, Genetics, Oncology +17

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications

Pascal Jézéquel, Olivier Kerdraon, Hubert Hondermarck et al. · Breast Cancer Research · 2019 · 118 citations · Full text

Life Sciences, Molecular Biology, Oncology +17